Investment Firm Upgrades Affy Stock Despite Disappointing Q1 Results | GenomeWeb

Investment Firm Upgrades Affy Stock Despite Disappointing Q1 Results

Apr 24, 2006

NEW YORK, April 24 (GenomeWeb News) - Investment firm Global Brown Capital upgraded Affymetrix's stock to "Overweight" from "Underweight" today despite the microarray company's disappointing first-quarter revenue and earnings, announced late last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Mouse Fight

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Seeing the Interactions

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

This Week in Science

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

For Millions

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.